Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial — CARE  

Fertility Risk Clinical Trial

Official title: Care Expansion Across Remote Environments - Substudy of the SELF-GYN [Sonograms Enable Looking Forward - Get Your iNformation] Extension - I Trial

Status Withdrawn

Clinical Trial Summary

This real-world, interventional sub-study will evaluate the impact of potential payer subsidies for Turtle Health at-home consults on subsequent interactions with the healthcare system within select sub-populations of interest.

Clinical Trial Description

The present study is a sub-study of the SELF-GYN1 study. The SELF-GYN1 study is a multicenter study designed to evaluate the efficacy and safety of the use of the Turtle Health Ultrasound Scanner for the acquisition of transvaginal ultrasound images by a study participant, with no previous training, in her home when guided by real-time remote supervision from a qualified and specially trained ultrasound technologist.

In addition to the main questions of the SELF-GYN1 study, additional questions related to patient decision-making and pricing dynamics for patients who purchase patient's decisions to purchase a fertility consult alongside enrolling in the SELF-GYN1 trial, will be studied at Mayo Clinic, through providing subsidies for the purchasing of the fertility consult. ;

Related Conditions & MeSH terms

• Fertility Risk

• NCT number: NCT05509322
• Study type: Interventional
• Source: Turtle Health, Inc.
• Status: Withdrawn
• Phase: N/A
• Start date: January 1, 2023
• Completion date: April 10, 2023